Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Gene Therapy Development
Viral Vectors in Molecular Biology and Gene Therapy
Adeno-associated viral (AAV) vectors dominate gene therapy due to their efficiency and safety, although challenges remain in addressing toxicity and expanding applications.
Immuno-Oncology Vs Chemotherapy: Exploring Treatment Synergies
Unpacking the potential of combining immuno-oncology and chemotherapy: understanding benefits, real-world impact, and addressing concerns.
Gene Therapy Development
Innovation Hubs for Gene Therapies: Advancing the Academic-Led Clinical Development of Novel Gene Therapies
The UK's cell and gene therapy sector is on the threshold of becoming a global leader in the field. While present challenges include the supply of equipment and skills gaps, Innovation Hubs aim to bridge these through collaboration.
Antibody & Protein Engineering
Amgen and Synaffix Pen $2 Billion
Amgen and Synaffix's partnership aims to revolutionise cancer treatment by developing highly targeted antibody-drug conjugates (ADCs).
Oligo Chemistry
Friedrich Miescher: The Pioneer of Nucleic Acid Discovery
As medical research that is founded on nucleic acids continues to progress, we take a step back to look at the man who first discovered nucleic acids.